The Scientific World Journal

The Scientific World Journal / 2006 / Article
Special Issue

Special Issue on Adolescent Health

View this Special Issue

Research Article | Open Access

Volume 6 |Article ID 372645 | https://doi.org/10.1100/tsw.2006.69

Kristin M. Rager, Amy Fowler, Hatim A. Omar, "Successful treatment of Depot Medroxyprogesterone acetate-related vaginal bleeding improves continuation rates in Adolescents", The Scientific World Journal, vol. 6, Article ID 372645, 3 pages, 2006. https://doi.org/10.1100/tsw.2006.69

Successful treatment of Depot Medroxyprogesterone acetate-related vaginal bleeding improves continuation rates in Adolescents

Academic Editor: Joav Merrick
Received01 Feb 2006
Revised01 Mar 2006
Accepted03 Mar 2006

Abstract

High discontinuation rates for depot medroxyprogesterone acetate (DMPA) in adolescents may contribute to the number of unintended pregnancies. Many cite vaginal bleeding as a reason for discontinuing DMPA use. In this study, we attempted to determine if treating DMPA-associated vaginal bleeding with monophasic oral contraceptive pills (OCP) raised continuation rates. A total of 131 patients who reported vaginal bleeding while on DMPA were included in this study and 83 were treated with monophasic OCP. Of those who received OCP, 38.7% reported that vaginal bleeding stopped completely, 51.8% reported that vaginal bleeding stopped temporarily, and 6.0% reported no change. Overall, 94% of enrolled patients who received OCP as a treatment for DMPA-associated vaginal bleeding continued DMPA use. Our findings indicate that vaginal bleeding due to DMPA can be successfully treated, leading to improvement in continuation rates.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views135
Downloads3232
Citations

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.